What Health Canada’s New Special Access Program Amendments Mean For Medical Access To Psychedelics Dec 23, 2021
Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder Dec 23, 2021
Humble & Fume Inc. Enters Exclusive Sales Representation Agreement with Galaxie Brands Inc. for the… Dec 22, 2021
Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase… Dec 22, 2021
Liquid Meta Coming To Market As DeFi’s Only Institutionally-Focused Application Provider Dec 21, 2021
